ストックスクリーナーアプリを入手
7.22
0.69%
-0.05
アフターアワーズ：
7.22
前日終値:
$7.27
開ける：
$7.27
24時間の取引高:
1.43M
Relative Volume:
1.53
時価総額：
$297.94M
収益：
$134.48M
当期純損益:
$-38.94M
株価収益率:
-7.5729
EPS:
-0.9534
ネットキャッシュフロー:
$-19.34M
1週間 パフォーマンス:
-0.82%
1か月 パフォーマンス:
-1.50%
6か月 パフォーマンス:
-8.61%
1年 パフォーマンス:
-50.62%
1日の値動き範囲:
$6.99
$7.44
1週間の範囲:
$6.57
$7.44
52週間の値動き範囲:
$5.90
$16.74
Rxsight Inc Stock (RXST) Company Profile
Compare RXST vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
7.22 | 300.01M | 134.48M | -38.94M | -19.34M | -0.9534 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | 開始されました | William Blair | Mkt Perform |
| 2025-07-15 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | ダウングレード | Jefferies | Buy → Hold |
| 2025-07-09 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-07-09 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-07-09 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | 開始されました | Piper Sandler | Neutral |
| 2025-04-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-04-04 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2025-04-03 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-12-20 | ダウングレード | Stifel | Buy → Hold |
| 2024-12-11 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 開始されました | UBS | Buy |
| 2024-10-29 | 開始されました | Jefferies | Buy |
| 2024-08-20 | 繰り返されました | Needham | Buy |
| 2024-08-06 | 繰り返されました | Needham | Buy |
| 2024-05-07 | 繰り返されました | BTIG Research | Buy |
| 2023-12-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | 開始されました | Stifel | Buy |
| 2023-12-04 | 開始されました | Morgan Stanley | Overweight |
| 2023-04-13 | 開始されました | Oppenheimer | Outperform |
| 2022-12-12 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | 開始されました | Needham | Buy |
すべてを表示
Rxsight Inc (RXST) 最新ニュース
Volume Summary: Will RxSight Inc benefit from geopolitical trends2026 Short Interest & Weekly Top Stock Performers List - baoquankhu1.vn
Trend Report: Is RxSight Inc forming a double bottom2026 Key Lessons & Stepwise Trade Signal Guides - baoquankhu1.vn
Retail Surge: Can RxSight Inc deliver consistent EPS growthWeekly Trend Summary & Fast Exit Strategy with Risk Control - baoquankhu1.vn
How (RXST) Movements Inform Risk Allocation Models - Stock Traders Daily
Needham Maintains RxSight (RXST) Buy Recommendation - MSN
Gains Report: What is RxSight Incs valuation compared to sector2026 Intraday Action & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Market Moves: Will RxSight Inc stock hit new highs in YEARQuarterly Earnings Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Analysis Recap: Will RxSight Inc benefit from geopolitical trendsJobs Report & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Investment Recap: Will RxSight Inc benefit from geopolitical trendsSwing Trade & Stepwise Trade Signal Guides - baoquankhu1.vn
RxSight Inc stock: 300,000 Lens Milestone Signals Growth Potential - AD HOC NEWS
RxSight Reaches 300,000 Light Adjustable Lens Implant Milestone - National Today
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026 - Sahm
RxSight, Inc. (RXST) stock price, news, quote and history - Yahoo Finance Australia
RxSight reports 300,000 Light Adjustable Lens implants milestone By Investing.com - Investing.com South Africa
RxSight reports 300,000 Light Adjustable Lens implants milestone - Investing.com
RxSight reaches 300,000 Light Adjustable Lens implants since launch - StreetInsider
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation | NDAQ:RXST | Press Release - Stockhouse
How The Story Is Shifting For RxSight (RXST) On Guidance Leadership And Valuation - Yahoo Finance
RXST PE Ratio & Valuation, Is RXST Overvalued - Intellectia AI
RxSight, Inc. (RXST) Stock Price, News, Quote & History - Yahoo! Finance Canada
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight to Participate in Annual Healthcare Conference - National Today
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
RXST SEC FilingsRxsight, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
RxSight management joins Needham virtual healthcare event Apr. 16 - Stock Titan
Earnings Risk: Will RxSight Inc stock hit new highs in YEAR2026 Year in Review & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
RXST Should I Buy - Intellectia AI
Trading Systems Reacting to (RXST) Volatility - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Aug Volume: What is RxSight Incs revenue forecast2026 Risk Factors & Accurate Technical Buy Alerts - baoquankhu1.vn
Vanguard realignment: RXST filings show 0 shares; subsidiaries report separately (RXST) - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Retail Trends: Is RxSight Inc a top pick in the sector2026 Price Targets & Low Drawdown Momentum Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc.(NasdaqGM:RXST) dropped from S&P Healthcare Equipment Select Industry Index - MarketScreener
Volume Recap: What is RxSight Incs valuation compared to sectorQuarterly Profit Summary & Reliable Breakout Forecasts - baoquankhu1.vn
How The RxSight (RXST) Investment Story Is Shifting With New Guidance And CFO Transition - Yahoo Finance
How Rxsight Inc. (RXST) Affects Rotational Strategy Timing - Stock Traders Daily
RxSight (NASDAQ: RXST) details CFO sign-on bonus and corrects option vesting - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - ACCESS Newswire
Breakout Watch: What is RxSight Incs revenue forecast2026 Opening Moves & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Aug Intraday: What is RxSight Incs revenue forecast2026 Biggest Moves & Entry Point Strategy Guides - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
RXST Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Tech Rally: Is CNTY affected by consumer sentiment2026 Geopolitical Influence & Advanced Technical Signal Analysis - baoquankhu1.vn
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
US Stocks Recap: What are the risks of holding RF Acquisition Corp IIPortfolio Performance Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Rxsight Inc (RXST) 財務データ
収益
当期純利益
現金流量
EPS
2.40%
0.00%
大文字化:
|
ボリューム (24 時間):